Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | HBB | P68871 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL10572250 | 0.98 | KDM4E (0.34) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL2009845 | 0.78 | KDM4E (0.35) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL29941283 | 0.75 | CHEK1 (0.36) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL1721317 | 0.75 | CHEK1 (0.36) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL1590661 | 0.74 | KDM4E (0.35) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL2968460 | 0.74 | KDM4E (0.35) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL5170025 | 0.74 | KDM4E (0.35) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL22430792 | 0.74 | KDM4E (0.35) | KDM4EALDH1A1HPGDGLAGAA | |
| SCHEMBL11486221 | 0.74 | KDM4E (0.35) | KDM4EALDH1A1HPGDGLAGAA | |
| 2-Aminopurine SCHEMBL29901502 | 0.74 | ALDH1A1 (0.48) | KDM4EALDH1A1HPGDGLAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119455413-A | Allopurinol desalination and evaporation device and desalination and evaporation method thereof | 宜兴市星宇药业有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119031915-A | Methods and compositions for treating skin proliferative disorders and other skin conditions | 不对称疗法有限责任公司 | 2024-11-26 | — | — | CN | claimed |
| WO-2023202686-A1 | COMPOSITION AND METHOD FOR INHIBITING XANTHINE DEHYDROGENASE (XDH) | 上海舶望制药有限公司 | 2023-10-26 | — | — | WO | claimed |
| CN-115968815-A | Induction method for efficiently producing full-male nibea albiflora triploid | 浙江省海洋水产研究所 | 2023-04-18 | — | — | CN | claimed |
| WO-2013181296-A2 | COMPOSITIONS AND METHODS FOR MANAGING WEIGHT | UNIGEN, INC. (US) | 2013-12-05 | — | — | WO | claimed |
| WO-2002092072-A2 | DRUGS FOR THE TREATMENT OF THE ALZHEIMER DISEASE | NICOX S.A. (FR) | 2002-11-21 | — | — | WO | claimed |
| EP-0741741-B1 | MODIFIED OLIGONUCLEOTIDES | NOVARTIS AG (CH) | 2002-08-28 | — | — | EP | claimed |
| US-6066447-A | INCLUDING NUCLEOSIDE DIMERS WITH MODIFIED BACKBONES; FOR VIRICIDES AND ANTISENSE AGENTS | NOVARTIS CORPORATION (US) | 2000-05-23 | — | — | US | claimed |
| US-6011112-A | SILYLATED ORGANONITROGEN COMPOUNDS | WACKER-CHEMIE GMBH (DE) | 2000-01-04 | — | — | US | claimed |
| EP-0852606-B1 | ORGANOPOLYSILOXANE COMPOUNDS CROSS-LINKABLE BY CLEAVING OF ALCOHOLS TO FORM ELASTOMERS | WACKER CHEMIE GMBH (DE) | 1999-04-14 | — | — | EP | claimed |
| WO-1995020597-A1 | MODIFIED OLIGONUCLEOTIDES | CIBA-GEIGY AG (CH) | 1995-08-03 | — | — | WO | claimed |
| EP-0644196-A1 | TTTr as a protecting group in nucleotide synthesis | CIBA-GEIGY AG (CH) | 1995-03-22 | — | — | EP | claimed |
| EP-0634927-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1995-01-25 | — | — | EP | claimed |
| US-5380521-A | Method for obtaining deodorant extract from tissue culture of plants in family oleaceae | MATSUSHITA ELECTRIC WORKS, LTD. (JP) | 1995-01-10 | — | — | US | claimed |
| US-5321032-A | Peptide compounds and pharmaceutical compositions thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-14 | — | — | US | claimed |
| EP-0577558-A2 | Carbocyclic nucleosides having bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates | CIBA-GEIGY AG (CH) | 1994-01-05 | — | — | EP | claimed |
| WO-1993017671-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1993-09-16 | — | — | WO | claimed |
| EP-0016845-B1 | METHOD AND TEST COMPOSITION FOR THE DETERMINATION OF A SUBSTRATE FOR XANTHINE-OXIDASE, INCLUDING A NOVEL XANTHINE-OXIDASE AND METHOD FOR THE PREPARATION THEREOF | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1983-07-13 | — | — | EP | claimed |
| US-4341868-A | PEROXIDATION; COLORIMETRY; QUANTITAVE ANALYSIS; ONE-STEP; ENTEROBACTER | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1982-07-27 | — | — | US | claimed |
| EP-0016845-A1 | METHOD AND TEST COMPOSITION FOR THE DETERMINATION OF A SUBSTRATE FOR XANTHINE-OXIDASE, INCLUDING A NOVEL XANTHINE-OXIDASE AND METHOD FOR THE PREPARATION THEREOF | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1980-10-15 | — | — | EP | claimed |